Table 1 Demonstrates data referring to gender, age, tumor localization, distribution by clinical staging, number of chemotherapy cycles, cumulative dose of cisplatin, dose by fraction and total dose of radiotherapy and the volume of radiotherapy treatment (n = 17).
Gender | Age | Localization | Staging Clínico | Number of cycles QT | Total Dose QT (mg) | Fraction Dose RT (Gy) | Total Dose RT (Gy) | VRTT (cm3) |
|---|---|---|---|---|---|---|---|---|
M | 54 | CEC Larynx | T4 N2 M0 | 7 | 336 | 1.8 | 70.2 | 1,390 |
M | 49 | CEC Larynx | T3 N3 M0 | 5 | 300 | 1.8 | 70.2 | 2,028 |
M | 71 | CEC Hypopharynx | T4 N2 M0 | 5 | 270 | 1.8 | 70.2 | 2,364 |
M | 51 | CEC Hypopharynx | T2 N2 M0 | 7 | 315 | 1.8 | 70.2 | 1,664 |
M | 61 | CEC Oropharynx | T4 N2 M0 | 8 | 400 | 1.8 | 70.2 | 1,480 |
M | 55 | CEC Oral Cavity | T2 N2 M0 | 8 | 336 | 1.8 | 72.2 | 1,550 |
M | 69 | CEC Hard Palate | T3 N1 M0 | 6 | 270 | 1.8 | 70.2 | 1,306 |
M | 51 | CEC Unseen | Tx N2 M0 | 8 | 220 | 1.8 | 70.2 | 739.64 |
M | 75 | CEC Base Tongue | T3 N3 M0 | 7 | 350 | 1.8 | 70.2 | 2,460 |
M | 69 | CEC Oropharynx | T4 N0 M0 | 2 | 96 | 2 | 68 | 1,392 |
F | 40 | CEC Larynx | T4 N0 M0 | 7 | 455 | 2 | 72 | 1,614 |
M | 57 | CEC Larynx | T4 N0 M0 | 6 | 258 | 1.8 | 70.2 | 1,488 |
M | 64 | CEC Larynx | T3 N3 M0 | 7 | 364 | 2 | 64 | 2,258 |
M | 58 | CEC Hypopharynx | T4 N3 M0 | 3 | 144 | 1.8 | 70.2 | 1,754 |
F | 68 | CEC Unseen | Tx N2 M0 | 7 | 378 | 2 | 60 | 3,364 |
M | 70 | CEC Oral Cavity | T2 N1 M0 | 7 | 399 | 2 | 64 | 1,728 |
M | 54 | CEC Oropharynx | T3 N0 M0 | 4 | 192 | 1.8 | 70.2 | 2,925 |